Cardiovascular Screening for Family Members of People With Acute Coronary Disease
1 other identifier
interventional
185
1 country
1
Brief Summary
Over a 12-month period, patients admitted with acute coronary disease to the cardiovascular care unit at the Jewish General Hospital (JGH), an academic tertiary care referral center in Montreal, Quebec, will be approached to refer first-degree relatives and/or household members age 18 years or older to an outpatient cardiovascular (CV) risk factor screening and treatment program. Relatives and household members will undergo a focused history, physical, and CV risk factor assessment and will receive evidence-based guideline-recommended treatment as indicated. Participants will be referred to nutritionists, smoking cessation programs, and to other allied healthcare professionals as needed. A follow-up visit at 6-months will assess treatment adherence and improvement in CV risk factors. All family and/or household members including the index patient will be encouraged to attend all healthcare visits together. The effectiveness of the screening strategy will be measured by the total number of participants identified as intermediate or high modified Framingham 10-year risk of cardiovascular disease. The effectiveness of the primary prevention intervention will be measured by the change in percentage of the mean modified Framingham 10-year risk score for participants between the initial visit and 6-month follow-up. The value of the referral, screening, and treatment program, as well as participant engagement and satisfaction will also be systematically evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2018
CompletedStudy Start
First participant enrolled
January 9, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedOctober 14, 2020
October 1, 2020
2.4 years
January 4, 2018
October 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in mean modified Framingham cardiovascular risk score from the initial visit to the 6 month follow-up visit
The change in percentage of the mean modified Framingham cardiovascular risk score for family and household members between the initial visit and the 6-month follow-up visit
6 months
Secondary Outcomes (1)
Effectiveness of the screening strategy
12 months of study recruitment
Study Arms (1)
Family or Household Members
EXPERIMENTALInterventions
An initial screening visit including a targeted history, physical exam, and investigations as per the Canadian Cardiovascular Society's recommendations for cardiovascular primary prevention. Counselling and informational handouts on improved cardiovascular risk factor and lifestyle habits. All family and household members, as well as the cardiovascular disease proband, are encouraged to attend and participate in all healthcare visits.
Eligibility Criteria
You may qualify if:
- Patient age ≤70 years old admitted with an initial diagnosis of an acute coronary event (such as acute coronary syndrome or myocardial infarction)
- At least 1 first-degree family or household member age ≥ 18 years old
You may not qualify if:
- No eligible family or household members
- Inability to contact family or household members
- Distance to study centre too far as determined by the patient
- Family or household members who have been screened for CV disease in the previous 2 years.
- Family or household members with known coronary disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital / Lady Davis Institute
Montreal, Quebec, H3T 1E2, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Goldfarb, MD
Lady Davis Institute for Medical Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician-Investigator
Study Record Dates
First Submitted
January 4, 2018
First Posted
February 22, 2018
Study Start
January 9, 2018
Primary Completion
May 30, 2020
Study Completion
May 30, 2020
Last Updated
October 14, 2020
Record last verified: 2020-10